Competitive Problems in the Drug Industry: Hearings, Ninetieth Congress, First Session. ..on Present Status of Competition in the Pharmaceutical Industry, 10. daļa
U.S. Government Printing Office, 1969
Lietotāju komentāri - Rakstīt atsauksmi
Ierastajās vietās neesam atraduši nevienu atsauksmi.
Citi izdevumi - Skatīt visu
additional advertising agents American animals appear Application asked Association autopsy believe blood caused changes charts clinical committee concerning CONGRESS continued copy cost Department detail developed discussed disease doctors dogs dosage dose Drug Administration effects equivalent evaluation evidence experiment eyes fact feel firm Food and Drug give given going Health hearings hospital important indicated individual industry institutions interest journals King laboratory letter LIBRARY manufacturers March material matter MCGILL Medicine Merrell monkey months observed patients period pharmaceutical physician possible practice prepared prescribing present problem profession promotion question rats reactions reason received record reference reports responsibility School Senator NELSON showed specific statement studies Subject submitted suggested sure testing therapeutic therapy things tion toxicity treatment University weight
3945. lappuse - No advertisement of a drug shall be deemed to be false if it is disseminated only to members of the medical profession, contains no false representation of a material fact, and includes, or is accompanied in each instance by truthful disclosure of, the formula showing quantitatively each ingredient of such drug.
4226. lappuse - Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved...
4263. lappuse - That any powers and duties of the Food and Drug Administration of the Department of Health, Education, and Welfare under the Federal Food, Drug, and Cosmetic Act, as amended (52 Stat.
3945. lappuse - ... (b) (1) A drug intended for use by man which "(A) is a habit-forming drug to which section 502 (d) applies; or "(B) because of its toxicity or other potentiality for harmful effect, or the method of its use. or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug...
3912. lappuse - Council, 2 East 63rd Street, New York 21, NY tDr. May is now Professor, Department of Pediatrics, New York University College of Medicine. ice of promotion? Is it prudent for physicians to become greatly dependent upon pharmaceutical manufacturers for support of scientific journals and medical societies, for entertainment, and now also for a large part of their education?
4257. lappuse - The operator of such establishment, the sponsor of the investigation, or the investigator has submitted...
4263. lappuse - SEC 1. The Attorney General of the United States, the Attorney of the United States in and for the District of Columbia, and the Corporation Counsel of the District of Columbia, and their assistants, regular and special, the justices, judges and clerks of all courts of record in the District of Columbia, and the...
3975. lappuse - The subcommittee met, pursuant to recess, at 10 :10 am, in room 318, Old Senate Office Building, Senator Gaylord Nelson (chairman of the subcommittee) presiding. Present: Senator Nelson. Also present : Benjamin Gordon, Staff Economist; and John Adams, Minority Counsel.
3958. lappuse - OUR FATHERS OF OLD" EXCELLENT herbs had our fathers of old Excellent herbs to ease their pain Alexanders and Marigold, Eyebright, Orris, and Elecampane. Basil, Rocket, Valerian, Rue, (Almost singing themselves they run) Vervain, Dittany, Call-me-to-you Cowslip, Melilot, Rose of the Sun. Anything green that grew out of the mould Was an excellent herb to our fathers of old.